✦ LIBER ✦

Randomized Phase III Trial of Cisplatin/Irinotecan Versus Cisplatin/Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer

✍ Scribed by Primo N. Lara Jr; David R. Gandara; Ronald B. Natale

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-156 Randomized, phase III trial compar

✍ Langer, C.; Hanna, N.; Einhorn, L.; Sandler, A.; Ansari, R.; Ellis, P.; Byrne, M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Safety of Irinotecan/Cisplatin Versus Et

✍ Lei Jiang; Ke-Hu Yang; Deng-hai Mi; Ya-Li Liu; Jin-Hui Tian; Bin Ma; Ji-Ying Tan 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 125 KB

Prospective Randomized Phase III Trial o

✍ Angel Artal-Cortés; Jose Gomez-Codina; Jose Luis Gonzalez-Larriba; Isidoro Barne 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 195 KB

E5501: phase II study of topotecan seque

✍ Owonikoko, Taofeek K.; Aisner, Joseph; Wang, Xin Victoria; Dahlberg, Suzanne E.; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 347 KB

Randomised phase II trial of irinotecan

✍ Sekine, I; Nokihara, H; Takeda, K; Nishiwaki, Y; Nakagawa, K; Isobe, H; Mori, K; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

Cisplatin–etoposide alternating with top

✍ Mavroudis, D; Veslemes, M; Kouroussis, Ch; Tzanakis, N; Ferdoutsis, E; Toumbis, 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 97 KB